Navigation Links
Collaboration needed for strengthening medical research in Europe
Date:2/5/2008

Public spending on medical research in Europe should be doubled over the next ten years to ensure health and welfare for Europes citizens and to nurture a thriving European medical research industry. There should be greater collaboration between European institutions in medical research and improved career paths for medical scientists.

These are some of the main recommendations of the European Medical Research Councils (EMRC) White Paper, Present Status and Future Strategy for Medical Research in Europe which was debated at a meeting on 30 January 2008 in Frankfurt (Germany) with the participation of the Heads of Medical Research Councils in Europe, Editors of Medical Journals, Presidents of Medical Learned Societies and Deans of Medical Faculties in Europe.

The audience acclaimed the White paper and made the following recommendations:

  • Increased funding must be by sustainable growth,
  • Collaboration on big programmes is essential,
  • Research areas should be determined by health priorities and not only science topics,
  • Collaboration on an improvement of peer review of grants is essential - and peer reviewers should be acknowledged and rewarded,
  • MD/PhD programmes are important and should be of high quality,
  • the best researchers - like the Nobel Laureates at The Lindau meeting - to participate in teaching,
  • Novel technologies and research infrastructures are important as well as incentive in terms of decent salaries to attract and retain young researchers

To make the White Paper recommendations come true European and global collaboration is needed.

The White Paper is the result of a comprehensive analysis of the current state of medical research within Europe together with an assessment of the new challenges facing Europes citizens, with changing patterns of disease, environmental issues as global warming, and changing demographic factors with an ageing population. The paper was launched at a meeting between Janez Potonik, EU Commissioner for Science and Research, and Professor Liselotte Hjgaard, Chair of the European Medical Research Councils in Brussels on 6 December 2007.

The White Paper key recommendations include:

  • Implementation of best practice for funding and performing medical research with distribution of funding in competition based on excellence and evaluated by peer review
  • Strengthened collaboration and coordination of medical research in Europe through the EMRC and its membership organisations, via the European Commission, the European Research Council and the learned medical societies
  • Revision of EC directives related to medical research
  • Implementation of equal opportunities for all researchers
  • A doubling of public funding of medical research in Europe within the next ten years to a minimum of 0.25% of gross domestic product (GDP)


'/>"/>
Contact: Liselotte Hjgaard
liselotte.hoejgaard@rh.regionh.dk
453-545-4215
European Science Foundation
Source:Eurekalert

Related medicine news :

1. Linguamatics and 81qd Sign Multi-Year Collaboration in Knowledge Discovery for Product Life Cycle Management
2. Wiley-Blackwell and the Cochrane Collaboration extend publishing partnership
3. IDM Pharma Announces Termination of UVIDEM Development Collaboration and Expected Restructuring in Connection With Evaluation of Strategic Alternatives
4. International research collaboration narrows focus on genetic cause of Kawasaki disease
5. BioSeek Initiates Systems Biology Compound Evaluation Collaboration with UCB
6. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
7. Xenome Enters Into Joint Research Collaboration to Discover Novel Peptide Therapeutics with Amylin Pharmaceuticals
8. Safeway Inc. and the Prostate Cancer Foundation to Fund Landmark Prostate Cancer Research Collaboration
9. Beactica Announces Drug Discovery Collaboration With Arrow Therapeutics
10. 3M, Gen-Probe to Discontinue Molecular Food Testing Collaboration
11. Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... May 27, 2016 , ... Two director-level employees of ... Tribute to Women and Industry (TWIN) 2016 honorees. The award recognizes businesswomen who ... this year, Geri Boone, Director of the MLTSS (Managed Long-Term Services and Supports) Program ...
(Date:5/27/2016)... ... 27, 2016 , ... With over 60 percent of acute stroke survivors being ... product to aid in the rehabilitation process has steadily increased. Ekso Bionics had been ... hemiplegia due to stroke. , Ekso Bionics has now received clearance from the U.S. ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... help educate the many who are unaware of the plight of aphasia. In ... run within the “Stroke Awareness” campaign. , The link between stroke and aphasia ...
(Date:5/27/2016)... ... , ... Aimed at nurses and employees in the health care world, this ... the nursing and health care industry. It also provides insight to the developing trends ... , As the nursing industry is coming out of one of the biggest recessions ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... Despite last ... meeting, expect Janet Yellen and company to wait until March 2017 for an interest ... University’s J. Mack Robinson College of Business. , “The Federal Open Market Committee (FOMC) ...
Breaking Medicine News(10 mins):
(Date:5/30/2016)... 30, 2016 LifeScienceIndustryResearch.com adds ... research report with comprehensive information on the therapeutic ... at various stages, therapeutics assessment by drug target, ... and molecule type, along with latest updates, and ... key players involved in the therapeutic development for ...
(Date:5/27/2016)... LONDON , May 27, 2016 ... an innovative biopharma company focused on the highly ... built a substantial pipeline of potential first-in-class or ... which are in development with strategic partners. HCM,s ... the fast-growing domestic market. We expect progress of ...
(Date:5/26/2016)... -- A key trend that will boost ... new treatments. Cardax, a development stage life sciences company, ... is expected to fulfil large unmet medical needs in ... to develop new treatments for osteoarthritis. One such study ... osteoarthritis are being investigated, and early trials of stem-cell ...
Breaking Medicine Technology: